Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadin 2 mg vs placebo for sleep quality in primary insomnia (age 55–80)
2004-000914-37Phase 3Completed
- Sponsor
- Neurim Pharmaceuticals
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Circadin 2 mg with Placebo (2 arms). Primary endpoint: Responder rate on LSEQ QOS and BFW variables. Started Feb 2005; status: completed.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2004-000914-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000914-37.